Clinical Trials
22 trialsNCT06279143 2026-05-26
dOCT-pBCC
Vejle Hospital
Completed
NCT01909453 2026-02-27
COLUMBUS
Pfizer
Phase 3 Completed
NCT07428941 2026-02-24
LegitHealth PH
AI Labs Group S.L
Completed
NCT07428954 2026-02-24
LegitHealthSAN
AI Labs Group S.L
Completed
NCT07429123 2026-02-24
Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
AI Labs Group S.L
Completed
NCT00026754 2025-04-18
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
Completed
NCT05060237 2024-10-17
Study to Evaluate Safety and Tolerability of BF-200 ALA (AmeluzĀ®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Phase 1 Completed
NCT05619471 2024-07-25
VISTA
Enspectra Health
Phase NA Completed
NCT05231044 2024-04-19
A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp
PharmaEssentia
Phase 3 Completed
NCT05410964 2024-01-30
VISION
Enspectra Health
Completed
NCT04834167 2023-11-30
OneDoc Picopulse⢠for the Treatment of Melasma Among Malaysian Women
Universiti Tunku Abdul Rahman
Phase NA Completed
NCT00847912 2021-06-11
VAKCCT
VA Office of Research and Development
Phase 4 Completed
NCT03285477 2021-04-13
AK003
Almirall, S.A.
Phase 3 Completed
NCT01763164 2021-03-22
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Pfizer
Phase 3 Completed
NCT01425749 2016-04-04
Mel55
University of Virginia
Phase EARLY_PHASE1 Completed
NCT00574392 2015-12-18
Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo
Memorial Sloan Kettering Cancer Center
Completed
NCT00753415 2015-03-17
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00785369 2012-10-03
In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis
Lucid
Phase NA Completed
NCT00894647 2010-08-31
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
Graceway Pharmaceuticals, LLC
Phase 3 Completed
NCT00668733 2010-07-20
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Graceway Pharmaceuticals, LLC
Completed
NCT00603798 2010-06-29
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
Graceway Pharmaceuticals, LLC
Phase 3 Completed
NCT00605176 2010-06-29
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
Graceway Pharmaceuticals, LLC
Phase 3 Completed